Intestinal disease secondary to tocilizumab
- PMID: 35656897
- DOI: 10.17235/reed.2022.8818/2022
Intestinal disease secondary to tocilizumab
Abstract
It is presented a case study of intestinal affectation on a patient under tocilizumab treatment for giant cell arteritis.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
